|
Product event summary: the data files were returned and analyzed.Four different patient files were returned.The first patient file confirmed system notice #50012 ¿the refrigerant delivery path is obstructed¿ in the start of ablation phase of the applications twelve through thirteen.The files showed at least thirteen applications were performed with the balloon catheter on the date of the event.The second patient file showed the system notice #50012 in the start of ablation phase of the applications one through four with the same catheter.Data files showed at least four applications were performed with the catheter on continue.The third patient file showed system notice #50012 in the start of ablation phase of the applications one, two, and four with the same catheter.Data files showed at least five applications were performed with the catheter on continue.The fourth patient file showed system notice #50012 in the start of ablation phase of the application one with the same catheter.Data files showed at least two applications were performed with the catheter on continue.In conclusion, the aborted under general anesthesia was a clinical issue that occurred during the case.A system notice #50012 ¿the refrigerant delivery path is obstructed¿ issue was confirmed for the reported date.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|